idea-ag.de
Contact us
About company
IDEA AG develops and commercializes non-invasive targeted therapeutics applied through the skin for delivery of drugs. The company uses Transfer some carriers for transporting the established molecular weight drugs selectively into the skin. It focuses on dermatological and pain therapeutics. The company’s Diractin is a ketoprofen in the Transfersome gel for the treatment of peripheral pain. IDEA AG was founded in 1993 and is based in Munich, Germany.
Unknown
Unknown
Not verified company
